Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_004612.4(TGFBR1):c.76_78delGCG(p.Ala26del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,041,918 control chromosomes in the GnomAD database, including 24 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
familial thoracic aortic aneurysm and aortic dissection
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Loeys-Dietz syndrome
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Loeys-Dietz syndrome 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 9-99105255-TGGC-T is Benign according to our data. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-99105255-TGGC-T is described in CliVar as Benign/Likely_benign. Clinvar id is 213863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00714 (1017/142520) while in subpopulation AFR AF = 0.0241 (948/39326). AF 95% confidence interval is 0.0228. There are 18 homozygotes in GnomAd4. There are 498 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0205
AC:
355
AN:
17354
American (AMR)
AF:
0.00503
AC:
14
AN:
2782
Ashkenazi Jewish (ASJ)
AF:
0.000274
AC:
2
AN:
7288
East Asian (EAS)
AF:
0.00142
AC:
13
AN:
9170
South Asian (SAS)
AF:
0.00205
AC:
37
AN:
18008
European-Finnish (FIN)
AF:
0.00254
AC:
13
AN:
5126
Middle Eastern (MID)
AF:
0.00155
AC:
3
AN:
1940
European-Non Finnish (NFE)
AF:
0.000337
AC:
272
AN:
806454
Other (OTH)
AF:
0.00150
AC:
47
AN:
31276
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.400
Heterozygous variant carriers
0
36
71
107
142
178
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00714
AC:
1017
AN:
142520
Hom.:
18
Cov.:
30
AF XY:
0.00718
AC XY:
498
AN XY:
69398
show subpopulations
African (AFR)
AF:
0.0241
AC:
948
AN:
39326
American (AMR)
AF:
0.00295
AC:
43
AN:
14554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3342
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4824
South Asian (SAS)
AF:
0.00152
AC:
7
AN:
4608
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8144
Middle Eastern (MID)
AF:
0.00752
AC:
2
AN:
266
European-Non Finnish (NFE)
AF:
0.0000774
AC:
5
AN:
64620
Other (OTH)
AF:
0.00605
AC:
12
AN:
1984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
37
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Oct 18, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
TGFBR1: BP3, BS1, BS2 -
not specifiedBenign:3
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 10, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Familial thoracic aortic aneurysm and aortic dissectionBenign:3
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Apr 03, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Apr 11, 2018
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndromeBenign:1
Apr 01, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children